Increased circulating advanced glycation endproducts (AGEs) in acute trauma patients.

about

Increased circulating advanced glycation endproducts (AGEs) in acute trauma patients.

Item

http://www.wikidata.org/entity/Q37227466

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Increased circulating advanced glycation endproducts (AGEs) in acute trauma patients.

@en

Increased circulating advanced glycation endproducts

@nl

type

Item

label

Increased circulating advanced glycation endproducts (AGEs) in acute trauma patients.

@en

Increased circulating advanced glycation endproducts

@nl

prefLabel

Increased circulating advanced glycation endproducts (AGEs) in acute trauma patients.

@en

Increased circulating advanced glycation endproducts

@nl

P1476

Increased circulating advanced glycation endproducts (AGEs) in acute trauma patients.

@en

P2093

Alan Livingstone

http://www.w3.org/2001/XMLSchema#string

Angela Castillo

http://www.w3.org/2001/XMLSchema#string

Carl I Schulman

http://www.w3.org/2001/XMLSchema#string

David C Landy

http://www.w3.org/2001/XMLSchema#string

Gary E Striker

http://www.w3.org/2001/XMLSchema#string

Helen Vlassara

http://www.w3.org/2001/XMLSchema#string

Jaime Uribarri

http://www.w3.org/2001/XMLSchema#string

Margaret Gallardo

http://www.w3.org/2001/XMLSchema#string

Nicholas Namias

http://www.w3.org/2001/XMLSchema#string

Ron Manning

http://www.w3.org/2001/XMLSchema#string

P2860

Advanced glycation end products in foods and a practical guide to their reduction in the diet

Deaths: final data for 2004.

Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy

Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation.

Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1

Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction.

Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1.

Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1.

Glyoxalase in diabetes, obesity and related disorders.

Maternal plasma advanced glycation end products concentrations in response to oral 50-gram glucose load in mid-pregnancy: a pilot study.

P304

103-108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1515/CCLM-2012-0834

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23612541

http://www.w3.org/2001/XMLSchema#string

P932

3795826

http://www.w3.org/2001/XMLSchema#string